Tested Applications
| Positive WB detected in | mouse brain tissue, human brain tissue |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
20144-1-AP targets BIRC8 in WB, ELISA applications and shows reactivity with human, mouse samples.
| Tested Reactivity | human, mouse |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag13658 Product name: Recombinant human BIRC8 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-236 aa of BC039318 Sequence: MTGYEARLITFGTWMYSVNKEQLARAGFYAIGQEDKVQCFHCGGGLANWKPKEDPWEQHAKWYPGCKYLLEEKGHEYINNIHLTRSLEGALVQTTKKTPSLTKRISDTIFPNPMLQEAIRMGFDFKDVKKIMEERIQTSGSNYKTLGVLVADLVSAQKDTTENELNQTSLQREISPEEPLRRLQEEKLCKICMDRHIAVVFIPCGHLVTCKQCAEAVDRCPMCSMVIDFKQRVFMS Predict reactive species |
| Full Name | baculoviral IAP repeat-containing 8 |
| Calculated Molecular Weight | 338aa,39 kDa; 236aa,27 kDa |
| Observed Molecular Weight | 30-35 kDa |
| GenBank Accession Number | BC039318 |
| Gene Symbol | BIRC8 |
| Gene ID (NCBI) | 112401 |
| RRID | AB_10732683 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q6PIA0 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Publications
What published studies show
The BIRC8 Polyclonal antibody (Cat# 20144-1-AP) has 1 citation. It appears in Oncotarget (2016), where it was used in Western blot to study the role of ARHGEF3 in promoting nasopharyngeal carcinoma cell pathogenesis by inhibiting cellular apoptosis. The associated research field is oncology, specifically tumor biology and apoptosis in head and neck cancers.
| Species | Application | Title |
|---|---|---|
Oncotarget The putative tumor activator ARHGEF3 promotes nasopharyngeal carcinoma cell pathogenesis by inhibiting cellular apoptosis. |



